EA.hy926 cells are a somatic hybrid cell line widely used in cardiovascular disease research. They are used to study various aspects of endothelial cell function related to angiogenesis, homeostasis/thrombosis, blood pressure regulation, and inflammation. The cytoplasmic distribution of Weibel-Palade bodies and tissue-specific organelles in EA.hy926 cells observed by electron micrographs reflects their differentiated endothelial cell function. A key advantage of EA.hy926 cells is their ability to undergo more than 100 population doublings (PDLs) while maintaining their cellular properties. This long lifespan ensures a sustainable and consistent source of cells for long-term experiments and studies. With a doubling time of 12 hours, these cells exhibit rapid proliferation, facilitating experimental workflows and enabling efficient generation of cell numbers required for large-scale studies.

https://www.creative-biogene.com/support/ea-hy926-cell-line.html

Creative Biogene

Creative Biogene provides kits, reagents, and services that help researchers explore questions about gene discovery, regulation, and function. Creative Biogene holds a leadership position in the global market and is committed to improving the human condition through biotechnology.
Creative Biogene is a US-based manufacturer and provider of genomics and proteomics products and services for academic and governmental research institutes, pharmaceutical and biotechnology industry.

Our Mission

To become the premier provider of innovative technologies, products, unique tools and services for research discoveries and product development in the areas of biological and biomedical research. Emphasis will be placed on the manufacture and distribution of genomics and proteomics based biological research reagent products of the highest possible quality, which include nucleic acid, protein and antibody based research reagent products and services.